Agilent Technologies prepares for IPO

Article

Newly spun-off Hewlett-Packard healthcare operation Agilent Technologies has filed a registration statement with the Securities and Exchange Commission for a proposed public offering, the company has announced. Agilent will offer 57 million shares of

Newly spun-off Hewlett-Packard healthcare operation Agilent Technologies has filed a registration statement with the Securities and Exchange Commission for a proposed public offering, the company has announced. Agilent will offer 57 million shares of common stock, 45.6 million offered in the U.S. and Canada, and 11.4 million of which will be offered internationally. Estimated IPO price per share is between $19 and $22, according to Agilent. Morgan Stanley Dean Witter and Goldman, Sachs & Company are handling the offering.

In March, Palo Alto, CA-based Hewlett-Packard spun off its medical products group, along with four other businesses, in an effort to focus on its computer business (SCAN 3/17/99). The name Agilent Technologies was chosen for the $8 billion Andover, MA, company in August (SCAN 8/4/99).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.